LEQEMBI IQLIK, approved by the U.S. FDA in August 2025, is the first and only anti-amyloid treatment to offer an at-home injection after initial treatment of 18 months ...
Bioxodes appoints industry veteran Philippe Monteyne as chairman as it accelerates late-stage development of breakthrough stroke candidateFormer GSK and Sanofi executive, led Cervarix® development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback